 |
VIENNA, March 30, 2023 /PRNewswire/ -- Croma (Croma-Pharma® GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio. Skin boosters are an important pillar of a minimally invasive aesthetics portfolio, next to HA fillers, botulinum toxin and PDO threads, allowing for combination therapies and a full-face approach. Read More
Contact:
Uschi Mayer
External Communications & PR
CROMA-PHARMA GmbH
Cromazeile 2, A-2100 Leobendorf, Austria
M.: +43 676 84 68 68 966
E: uschi.mayer@croma.at
Logo: https://mma.prnasia.com/media2/2044449/Croma_Pharma_Logo.jpg?p=medium600
![[Area under the receiver operating characteristic (ROC) curve of a deep learning algorithm model for predicting obstructive sleep apnea (OSA).]](https://mma.prnasia.com/media2/2553689/Area_under_the_receiver_operating_characteristic__ROC__curve_of_a_deep_learning_algorithm_model_for.jpg?p=medium600)
